TEC Assessments in Press
April 2008
The following Assessments from the February 2007 Medical Advisory Panel (MAP) teleconference are in press.
Please also note that the draft “Special Report: Appraising Evidence Supporting a Role for Genetic Markers Assessing Disease Predisposition and Prognosis, or Predicting Response to Therapy” was tabled at the February teleconference meeting for additional revision.
Please also note that the draft "Genetic Testing for Early Onset Familial Alzheimer's Disease" was tabled at the October meeting for revision and expert input. The revised draft will be presented at the June 2008 MAP meeting.
_____________________________________________________________________
NOTICE OF PURPOSE: TEC Assessments are scientific opinions, provided solely for informational purposes. TEC Assessments should not be construed to suggest that the Blue Cross Blue Shield Association, Kaiser Permanente Medical Care Program or the TEC Program recommends, advocates, requires, encourages, or discourages any particular treatment, procedure, or service; any particular course of treatment, procedure, or service; or the payment or non-payment of the technology or technologies evaluated.
